Home When one disease is not enough: succinyl-CoA: 3-oxoacid coenzyme A transferase (SCOT) deficiency due to a novel mutation in OXCT1 in an infant with known phenylketonuria
Article
Licensed
Unlicensed Requires Authentication

When one disease is not enough: succinyl-CoA: 3-oxoacid coenzyme A transferase (SCOT) deficiency due to a novel mutation in OXCT1 in an infant with known phenylketonuria

  • Jan-Niclas Schwade , Matthias Endmann , Thomas Hofmann , Stephan Rust , Jörn Oliver Sass and Frank Rutsch EMAIL logo
Published/Copyright: August 18, 2017

Abstract

A 9-month-old Turkish girl was admitted several times within 3 months to the hospital in reduced general condition and with extreme tachypnea. The patient had been diagnosed with phenylketonuria (PKU) in newborn screening and has been treated with a low phenylalanine diet and amino acid supplements. Each time an unexplained pronounced metabolic acidosis was noted, and the child was treated with sodium-bicarbonate and glucose-electrolyte infusions. The acidosis with only slightly abnormal glucose, normal lactate levels and pronounced ketonuria suggested a defect in ketone body utilization. Succinyl-CoA: 3-oxoacid CoA transferase (SCOT) enzyme activity was low in patient’s fibroblasts. Mutation analysis of the corresponding OXCT1 gene revealed that the patient was a homozygous carrier of the mutation c.1523T>C (p.V508A). We conclude that SCOT deficiency should be considered in the differential diagnosis in patients with recurrent metabolic acidotic episodes, even if they are already known to have a metabolic disease unrelated to this.


Corresponding author: Frank Rutsch, MD, Department of General Pediatrics, Münster University Children’s Hospital, Münster, Albert-Schweitzer-Campus 1, Gbde. A1, 48149 Münster, Germany

Acknowledgments

We are grateful to Miriam Petersen and Sibylle Flössner (MVZ Dr. Eberhard & Partner Dortmund, Dortmund, Germany) for enzyme activity testing and Ingrid Du Chesne (Münster University Children’s Hospital) for mutation analysis.

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Sass JO. Inborn errors of ketogenesis and ketone body utilization. J Inherit Metab Dis 2012;35:23–8.10.1007/s10545-011-9324-6Search in Google Scholar PubMed

2. van Hasselt PM, Ferdinandusse S, Monroe GR, Ruiter JP, Turkenburg M, et al. Monocarboxylate transporter 1 deficiency and ketone utilization. N Engl J Med 2014;371:1900–7.10.1056/NEJMoa1407778Search in Google Scholar PubMed

3. Balasubramaniam S, Lewis B, Greed L, Meili D, Flier A, et al. Heterozygous monocarboxylate transporter 1 (MCT1, SLC16A1) deficiency as a cause of recurrent ketoacidosis. JIMD Rep 2016;29:33–8.10.1007/8904_2015_519Search in Google Scholar PubMed

4. Sass JO, Grünert S. Disorders of ketone body metabolism. In: Blau N, Duran M, Gibson KM, Dionisi-Vici C, editors. Physician’s guide to the diagnosis, treatment, and follow-up of inherited metabolic diseases. Heidelberg, Berlin: Springer-Verlag, 2014:361–71.Search in Google Scholar

5. Mitchell GA, Fukao T. Inborn errors of ketone body catabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease, 8th ed. New York: McGraw-Hill, 2001:2327–56.Search in Google Scholar

6. Fukao T, Song XQ, Yamaguchi S, Hashimoto T, Orii T, et al. Immunotitration analysis of cytosolic acetoacetyl-coenzyme A thiolase activity in human fibroblasts. Pediatr Res 1996;39:1055–8.10.1203/00006450-199606000-00020Search in Google Scholar PubMed

7. Sakazaki H, Hirayama K, Murakami S, Yonezawa S, Shintaku H, et al. A new Japanese case of succinyl-CoA: 3-ketoacid CoA-transferase deficiency. J Inherit Metab Dis 1995;18:323–5.10.1007/BF00710423Search in Google Scholar PubMed

8. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265–75.10.1016/S0021-9258(19)52451-6Search in Google Scholar PubMed

9. Posey JE, Harel T, Liu P, Rosenfeld JA, James RA, et al. Resolution of disease phenotypes resulting from multilocus genomic variation. N Engl J Med 2017;376:21–31.10.1056/NEJMoa1516767Search in Google Scholar PubMed PubMed Central

Received: 2017-5-1
Accepted: 2017-7-17
Published Online: 2017-8-18
Published in Print: 2017-10-26

©2017 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Review
  3. Individualised growth response optimisation (iGRO) tool: an accessible and easy-to-use growth prediction system to enable treatment optimisation for children treated with growth hormone
  4. Original Articles
  5. Relation of insulin resistance to neurocognitive function and electroencephalography in obese children
  6. Body weight misperception and health-related factors among Iranian children and adolescents: the CASPIAN-V study
  7. Do sufficient vitamin D levels at the end of summer in children and adolescents provide an assurance of vitamin D sufficiency at the end of winter? A cohort study
  8. Type 3 renal tubular acidosis associated with growth hormone deficiency
  9. Serum α-klotho levels are not informative for the evaluation of growth hormone secretion in short children
  10. Evaluation of neurodevelopment of children with congenital hypothyroidism by the Denver Developmental Screening Test
  11. Pediatric differentiated thyroid carcinoma: trends in practice and outcomes over 40 years at a single tertiary care institution
  12. Physical activity and bone mineral density at the femoral neck subregions in adolescents with Down syndrome
  13. A pilot study on the utility of reduced urine collection frequency protocols for the assessment of reproductive hormones in adolescent girls
  14. MODY in Ukraine: genes, clinical phenotypes and treatment
  15. A retrospective review of initial bisphosphonate infusion in an inpatient vs. outpatient setting for bisphosphonate naïve patients
  16. Molecular genetic and clinical delineation of 22 patients with congenital hypogonadotropic hypogonadism
  17. Letter to the Editor
  18. Rare cases of galactose metabolic disorders: identification of more than two mutations per patient
  19. Case Reports
  20. When one disease is not enough: succinyl-CoA: 3-oxoacid coenzyme A transferase (SCOT) deficiency due to a novel mutation in OXCT1 in an infant with known phenylketonuria
  21. Pseudohypoparathyroidism type 1B associated with assisted reproductive technology
  22. Long QT syndrome diagnosed in two sisters with propionic acidemia: a case report
  23. Delayed diagnosis of proopiomelanocortin (POMC) deficiency with type 1 diabetes in a 9-year-old girl and her infant sibling
Downloaded on 17.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2017-0177/html
Scroll to top button